Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Depomed Inc (NASDAQ:DEPO)

18.97
Delayed Data
As of Jul 29
 -0.28 / -1.45%
Today’s Change
12.25
Today|||52-Week Range
33.11
+4.63%
Year-to-Date
Depomed (DEPO) Weak On High Volume
Jul 27 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close19.25
Today’s open19.37
Day’s range18.92 - 19.40
Volume694,800
Average volume (3 months)1,656,195
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)-161.46%
Earnings growth (this year)+70.01%
Earnings growth (next 5 years)+24.00%
Revenue growth (last year)-12.20%
P/E ratioNM
Price/Sales3.18
Price/Book3.61

Competitors

 Today’s
change
Today’s
% change
TBPHTheravance Biopharma...+1.14+4.68%
ACHNAchillion Pharmaceut...+0.01+0.12%
LCILannett Company Inc+0.11+0.35%
INSYINSYS Therapeutics I...+0.01+0.06%
Data as of 4:01pm ET, 07/29/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)$0.25
Annual revenue (last year)$342.7M
Annual profit (last year)-$75.7M
Net profit margin-22.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
James A. Schoeneck
CFO, Senior VP &
Head-Investor Relations
August J. Moretti
Corporate headquarters
Newark, California

Forecasts

Partner Offers

Search for Jobs